Suppr超能文献

肝细胞癌-胆管细胞癌混合癌及其类似物:外科病理学诊断中的陷阱。

Combined hepatocellular-cholangiocarcinoma and its mimickers: Diagnostic pitfalls in surgical pathology.

机构信息

Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand; Division of Pathology, Thammasat University Hospital, Pathumthani, Thailand.

Department of Pathology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

出版信息

Ann Diagn Pathol. 2021 Aug;53:151770. doi: 10.1016/j.anndiagpath.2021.151770. Epub 2021 Jun 16.

Abstract

BACKGROUND

The diagnosis of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) requires histomorphological detection of both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). However, these primary liver cancers (PLCs) have a wide variety of microscopic appearances resulting in difficulties and uncertainties in cHCC-CCA's diagnosis. This study aims to perform a clinicopathologic analysis on the diagnosis of PLCs at a tertiary referral hospital in Thailand using traditional morphologic studies.

METHODS

A 5-year retrospective analysis of pathologically diagnosed PLCs was conducted. Pathological features and clinical characteristics of cHCC-CCA and other PLCs with the histopathologic resemblance to cHCC-CCA were studied. The pathological diagnosis was rendered based on histomorphological context rather than immunoreactivity. A literature review containing diagnostic pitfalls of cHCC-CCA was carried out.

RESULTS

PLCs from a total of 295 patients were retrieved, and cHCC-CCA accounted for 1.4% (n = 4) of the malignancies. Histomorphological evaluation is the most reliable diagnostic modality for cHCC-CCA. Extremely uncommon variants of iCCA (i.e., mucinous iCCA and adenosquamous iCCA) and iCCA arising with hepatocellular nodular lesions (i.e., iCCA with nodular regenerative hyperplasia (NRH), and iCCA in cirrhosis) could have a histomorphologic resemblance to that of cHCC-CCA.

CONCLUSIONS

Although there has been an exceedingly high incidence of iCCA in Thailand, such a commonness is not valid for cHCC-CCA in our series. Rare forms of iCCA could have a morphologic resemblance to that of cHCC-CCA. Regardless of the differentiation and immunophenotype, iCCA without a distinct HCC component should never be diagnosed as cHCC-CCA.

摘要

背景

混合肝细胞癌-胆管细胞癌(cHCC-CCA)的诊断需要通过组织形态学检测同时发现肝细胞癌(HCC)和肝内胆管癌(iCCA)。然而,这些原发性肝癌(PLC)具有广泛的微观表现,导致 cHCC-CCA 诊断存在困难和不确定性。本研究旨在使用传统形态学研究对泰国一家三级转诊医院的 PLC 进行临床病理分析。

方法

对经病理诊断的 PLC 进行了为期 5 年的回顾性分析。研究了 cHCC-CCA 和其他与 cHCC-CCA 具有组织形态学相似性的 PLC 的病理特征和临床特征。病理诊断基于组织形态学背景,而不是免疫反应。进行了包含 cHCC-CCA 诊断陷阱的文献复习。

结果

共检索到 295 例 PLC 患者,cHCC-CCA 占恶性肿瘤的 1.4%(n=4)。组织形态学评估是 cHCC-CCA 最可靠的诊断方法。极罕见的 iCCA 变体(即黏液性 iCCA 和腺鳞 iCCA)和伴有肝细胞结节病变的 iCCA(即 iCCA 伴结节性再生性增生(NRH)和肝硬化中的 iCCA)可能具有与 cHCC-CCA 相似的组织形态学表现。

结论

尽管泰国的 iCCA 发病率极高,但在我们的研究系列中,cHCC-CCA 并非如此常见。罕见形式的 iCCA 可能具有与 cHCC-CCA 相似的形态学表现。无论分化和免疫表型如何,没有明确 HCC 成分的 iCCA 不应被诊断为 cHCC-CCA。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验